文献速递生殖医学母胎医学

ICSI与染色体异常关联的系统综述与荟萃分析

A systematic review and meta-analysis on the association between ICSI and chromosome abnormalities.
PubMed 文献 · Hum Reprod Update · 2021-01-01

该研究系统检索并荟萃分析ICSI与子代染色体异常的相关证据,共纳入27篇文献、19篇进入定量合成。调整后数据未显示ICSI较标准IVF或自然妊娠增加总体染色体异常风险,但未调整数据提示风险升高;证据确定性极低。

要点

  • 调整后数据:ICSI vs IVF的总体染色体异常aOR 0.75(95%CI 0.41-1.38),无统计学意义。
  • 调整后数据:ICSI vs 自然妊娠的总体染色体异常aOR 1.29(95%CI 0.69-2.43),无统计学意义。
  • 证据确定性极低,仅5项研究可用于调整数据合并分析,所有研究存在严重偏倚风险。

核心结论

  • 基于极低确定性证据,未发现ICSI子代染色体异常风险增加的明确指征,若存在绝对风险也较小。

研究设计与样本

  • 初检4648篇文献,27篇符合纳入标准,19篇进入定量合成(荟萃分析)。

主要发现

  • 各研究间染色体异常患病率差异较大,可能与样本量和患者人群特征差异有关。
  • 仅5项研究符合调整数据合并分析条件;所有研究均存在严重偏倚风险。
  • 未调整数据荟萃分析显示ICSI较标准IVF总体染色体异常风险升高(OR 1.42,95%CI 1.09-1.85)。
  • 未调整数据荟萃分析显示ICSI较自然妊娠总体染色体异常风险升高(OR 2.46,95%CI 1.52-3.99)。
  • 未调整数据荟萃分析显示ICSI较自然妊娠新发异常风险升高(OR 2.62,95%CI 2.07-3.31)。

关键数值与推荐

  • 主要结局为总体染色体异常和新发异常(含性染色体异常和常染色体异常),次要结局为遗传性异常。
  • 调整后数据:ICSI vs 标准IVF总体染色体异常aOR 0.75(95% CI 0.41-1.38)。
  • 调整后数据:ICSI vs 自然妊娠总体染色体异常aOR 1.29(95% CI 0.69-2.43)。

临床怎么用

  • 咨询时应告知ICSI子代染色体异常风险增加的证据确定性极低,调整后数据未显示明确风险升高。
  • 避免基于未调整数据的阳性关联过度解读ICSI的遗传风险。

局限性

  • 所有纳入研究均存在严重偏倚风险。
  • 仅5项研究可纳入调整数据合并分析,现有数据有限。
  • 各研究间染色体异常患病率差异大,可能与样本量和人群特征差异有关。
  • 证据确定性极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the decade following the introduction of ICSI, a higher prevalence of de novo chromosome abnormalities, in particular sex chromosome and autosomal structural abnormalities, as well as inherited abnormalities was described in children conceived by ICSI compared to both naturally conceived (NC) children and children conceived by standard IVF. The explanation for the observed increase in prevalence is not clear and has been suggested to reflect parental factors (e.g. age or sperm quality) or to be a result of the ICSI procedure itself. Over the years, the procedure, as well as the patient group, and indications for ICSI treatment have changed. OBJECTIVE AND RATIONALE: The objective of this systematic review and meta-analysis was to assess the prevalence of chromosome abnormalities in ICSI pregnancies and children and to examine any potentially increased risk compared to standard IVF and NC. SEARCH METHODS: Pubmed, Embase, Cochrane Libraries and Web of Science up to October 2020 were searched. Primary outcome measures were overall chromosome abnormalities and de novo abnormalities (including sex chromosome abnormalities and autosomal abnormalities). The secondary outcome was inherited abnormalities. We followed the PRISMA guidelines and relevant meta-analyses were performed. OUTCOMES: The search included 4648 articles, out of which 27 met the inclusion criteria, and 19 were included in quantitative synthesis (meta-analyses). The prevalence of chromosome abnormalities varied considerably between studies, possibly explained by large differences in sample size and patient demographics. Only five studies were eligible for pooled analyses on adjusted data. All studies had a critical risk of bias. Results from pooled adjusted data showed no evidence of an increased risk of overall chromosome abnormalities when comparing ICSI to either standard IVF (aOR 0.75 (95% CI 0.41-1.38)) or NC (aOR 1.29 (95% CI 0.69-2.43)). In contrast, meta-analyses on unadjusted data showed an increased risk of overall chromosome abnormalities in ICSI compared to both standard IVF (OR 1.42 (95% CI 1.09-1.85)) and NC (OR 2.46 (95% CI 1.52-3.99)) and an increased risk of de novo abnormalities in ICSI compared to NC (OR 2.62 (95% CI 2.07-3.31)). Yet, based on a very low certainty of evidence, the conclusion remains, that no indication of an increased risk of chromosome abnormalities in ICSI offspring could be found. If an increased risk of chromosome abnormalities in selected ICSI offspring should exist, the absolute risk continues to be small. WIDER IMPLICATIONS: This review provides an extensive overview of the existing evidence on the relationship between ICSI and chromosome abnormalities in the offspring. We highlight the need for well-designed large, prospective, controlled studies with systematic cytogenetic testing. Existing data are limited and, in many cases, marred by critical levels of bias.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Berntsen S, Laivuori H, la Cour Freiesleben N, et al. A systematic review and meta-analysis on the association between ICSI and chromosome abnormalities. Hum Reprod Update. 2021. PMID: 33956940. doi:10.1093/humupd/dmab005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。